Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · see citing works

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463 · see citing works

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016 · see citing works

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Smolen, J. S., Landewé, R., Bijlsma, J. W. J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 7,468 · see citing works

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030 · see citing works

IL‐6 in inflammation, immunity, and disease

Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · see citing works

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · see citing works

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · see citing works

Kidney disease is associated with in-hospital death of patients with COVID-19

Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,957 · see citing works

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

ZHANG, W., & LIU, H. T. (2002) · Cell Research · doi:10.1038/sj.cr.7290105 · Cited by 2,845 · see citing works

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Smolen, J. S., Landewé, R., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A. R., van Vollenhoven, R., de Wit, M. P. T., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,753 · see citing works

Effective treatment of severe COVID-19 patients with tocilizumab

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,636 · see citing works

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works

Rheumatoid arthritis

Smolen, J. S., Aletaha, D., Barton, A. C., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,480 · see citing works

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J. C., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,237 · see citing works

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,007 · see citing works

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · see citing works

COVID-19: immunopathology and its implications for therapy

Cao, X. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0308-3 · Cited by 1,609 · see citing works

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Liu, K., Fang, Y.-Y., Deng, Y., Liu, W. Y., Wang, M., Ma, J.-P., Xiao, W. L., Wang, Y.-N., Zhong, M.-H., Li, C.-H., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000744 · Cited by 1,412 · see citing works

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works

Multiple organ infection and the pathogenesis of SARS

Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379 · see citing works

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway

Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,342 · see citing works

Tocilizumab treatment in COVID‐19: A single center experience

Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25801 · Cited by 1,235 · see citing works

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076 · see citing works

Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063 · see citing works

Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, ChinaPreprint

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Yu, T., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898 · see citing works

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Schwab, I., & Nimmerjahn, F. (2013) · Nature reviews. Immunology · doi:10.1038/nri3401 · Cited by 820 · see citing works

Phenotypical and functional specialization of FOXP3+ regulatory T cells

Campbell, D. J., & Koch, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2916 · Cited by 773 · see citing works

Mechanism of NLRP3 inflammasome activation

Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736 · see citing works

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M. H., Gossec, L., van der Heijde, D. M. F. M., Winthrop, K. L., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701 · see citing works

[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].

Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 690 · see citing works

An interferon‐γ‐related cytokine storm in SARS patients

Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679 · see citing works

Hydroxychloroquine: From Malaria to Autoimmunity

Ben‐Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 616 · see citing works

Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection

Arabi, Y. M., Arifi, A. A., Balkhy, H. H., Najm, H. K., Al‐Dawood, A., Ghabashi, A., Hawa, H., Alothman, A. F., Al-Khaldi, A., & Raiy, B. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2486 · Cited by 573 · see citing works

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

Totura, A. L., Whitmore, A. C., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 479 · see citing works

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells

Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S. F., Wu, M. H. S., Chan, K., Yuen, K., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461 · see citing works

Newly described pattern recognition receptors team up against intracellular pathogens

Brož, P., & Monack, D. M. (2013) · Nature reviews. Immunology · doi:10.1038/nri3479 · Cited by 459 · see citing works

Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis

Zhou, J., Chu, H., Li, C., Wong, B. H., Cheng, Z., Poon, V. K., Sun, T., Lau, C. C.-Y., Wong, K. K. Y., Chan, J. Y. W., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 429 · see citing works

IL-10: A Multifunctional Cytokine in Viral Infections

Rojas, J. M., Avia, M., Martı́n, V., & Sevilla, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/6104054 · Cited by 414 · see citing works

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment

Lau, S. K. P., Lau, C. C. Y., Chan, K., Li, C. P. Y., Chen, H., Jin, D., Chan, J. F., Woo, P. C. Y., & Yuen, K. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 393 · see citing works

Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386 · see citing works

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China

Shi, Y., Tan, M., Chen, X., Liu, Y., Huang, J., Ou, J., & 邓西龙 (2020) · Immunology · doi:10.1111/imm.13223 · Cited by 376 · see citing works

The Diverse Function of PD-1/PD-L Pathway Beyond Cancer

Qin, W., Hu, L.-P., Zhang, X., Jiang, S., Li, J., Zhang, Z., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02298 · Cited by 371 · see citing works

The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph NodesPreprint

Feng, Z., Diao, B., Wang, R., Wang, G., Wang, C., Tan, Y., Liu, L., Wang, C., Liu, Y., Liu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.27.20045427 · Cited by 369 · see citing works

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Yang, Z., Liu, J., Zhou, Y., Zhao, Q., Zhao, Q., & Liu, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.062 · Cited by 361 · see citing works

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Li, J., Guo, M., Tian, X., Wang, X., Yang, X., Wu, P., Liu, C., Xiao, Z., Qu, Y., Yin, Y., et al. (2020) · Med · doi:10.1016/j.medj.2020.07.002 · Cited by 352 · see citing works

Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)

Zha, L., Li, S., Lingling, P., Tefsen, B., Li, Y., French, N., Chen, L., Yang, G., & Villanueva, E. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50577 · Cited by 345 · see citing works

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

Michot, J., Albiges, L. K., Chaput, N., Saada, V., Pommeret, F., Griscelli, F., Balleyguier, C., Besse, B., Marabelle, A., Netzer, F., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.300 · Cited by 336 · see citing works

FRI0203 A SINGLE-CENTER INVESTIGATION ON THE PREVALENCE OF MALIGNANCIES IN PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS BY WAY OF 18F-FDG PET/CT: A PROSPECTIVE COHORT STUDY

Emamifar, A., Hess, S., Gerke, O., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-eular.2238 · Cited by 324 · see citing works

Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses

Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. M., Proll, S. C., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 307 · see citing works

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.

Sciascia, S., Aprà, F., Baffa, A., Baldovino, S., Boaro, D., Boero, R., Bonora, S., Calcagno, A., Cecchi, I., Cinnirella, G., et al. (2020) · PubMed · Cited by 303 · see citing works

Suppressed T Cell-Mediated Immunity in Patients with COVID-19: A Clinical Retrospective Study in Wuhan, China

Xu, B., Fan, C.-Y., Wang, A., Yi-long, Z. O. U., Yu, Y., He, C., Xia, W., Zhang, J., & Miao, Q. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.012 · Cited by 302 · see citing works

Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock

Alejandria, M. M., Lansang, M. A., Dans, L. F., & Mantaring, J. B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090.pub2 · Cited by 301 · see citing works

Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients

Wan, S.-X., Yi, Q., Fan, S., Lv, J.-L., Zhang, X.-X., Guo, L., Lang, C.-H., Xiao, Q., Xiao, K., Yi, Z.-J., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16659 · Cited by 299 · see citing works

Hyperimmune IV Immunoglobulin Treatment

Hung, I. F., To, K. K., Lee, C. K., Lee, K., Yan, W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K. I., Chow, F., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-2907 · Cited by 287 · see citing works

Clinical review: Blood purification for sepsis

Rimmel�, T., & Kellum, J. A. (2011) · Critical Care · doi:10.1186/cc9411 · Cited by 279 · see citing works

Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome

Li, T., Qiu, Z., Zhang, L., Han, Y., He, W., Liu, Z., Ma, X., Fan, H., Lu, W., Xie, J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381535 · Cited by 279 · see citing works

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

Sepriano, A. R., Kerschbaumer, A., Smolen, J. S., van der Heijde, D. M. F. M., Dougados, M., van Vollenhoven, R., McInnes, I. B., Bijlsma, J. W. J., Burmester, G. R., de Wit, M. P. T., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216653 · Cited by 277 · see citing works

Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung

Dienz, O., Rud, J., Eaton, S. M., Lanthier, P. A., Burg, E., Drew, A., Bunn, J., Suratt, B. T., Haynes, L., & Rincón, M. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.2 · Cited by 276 · see citing works

Treatment of Severe Acute Respiratory Syndrome With Glucosteroids

Chen, R.-C., Tang, X.-P., Tan, S.-Y., Bi-ling, L., Wan, Z. Y., Fang, J.-Q., & Zhong, N. (2006) · CHEST Journal · doi:10.1378/chest.129.6.1441 · Cited by 275 · see citing works

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*

Hotchkiss, R. S., Colston, E., Yende, S. P., Angus, D. C., Moldawer, L. L., Crouser, E. D., Martin, G. S., Coopersmith, C. M., Brakenridge, S. C., Mayr, F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003685 · Cited by 253 · see citing works

The Immunobiology of SARS

Chen, J., & Subbarao, K. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141706 · Cited by 252 · see citing works

First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

Zhang, X., Song, K., Tong, F., Fei, M., Guo, H., Lu, Z., Wang, J., & Zheng, C. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001907 · Cited by 250 · see citing works

Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids

Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242 · see citing works

Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients

Al‐Tawfiq, J. A., Hinedi, K., Ghandour, J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu226 · Cited by 235 · see citing works

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

Zhou, W., Liu, Y., Tian, D., Wang, C., Wang, S., Cheng, J., Hu, M., Fang, M., & Gao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0127-9 · Cited by 234 · see citing works

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation

Ristimaki, A. P., Narko, K., & Hla, T. (1996) · Biochemical Journal · doi:10.1042/bj3180325 · Cited by 232 · see citing works

Anti-malarial agent artesunate inhibits TNF- -induced production of proinflammatory cytokines via inhibition of NF- B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes

Xu, H., He, Y., Yang, X., Liang, L., Zhan, Z., Ye, Y., Yang, X., Lian, F., & Sun, L. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem014 · Cited by 222 · see citing works

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Hotchkiss, R. S., Colston, E., Yende, S. P., Crouser, E. D., Martin, G. S., Albertson, T. E., Bartz, R. R., Brakenridge, S. C., Delano, M. J., Park, P. K., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05704-z · Cited by 212 · see citing works

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019Preprint

Chen, G., Wu, D., Guo, W., et al. (2020) · medRxiv · doi:10.1101/2020.02.16.20023903 · Cited by 209 · see citing works

The Use of Antimalarial Drugs against Viral Infection

D’Alessandro, S., Scaccabarozzi, D., Signorini, L., Perego, F., Ilboudo, D. P., Ferrante, P., & Delbue, S. (2020) · Microorganisms · doi:10.3390/microorganisms8010085 · Cited by 174 · see citing works

Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome

Radbel, J. M., Narayanan, N., & Bhatt, P. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.024 · Cited by 172 · see citing works

Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation

Shapira, M. Y., Resnick, I. B., Chou, S., Neumann, A. U., Lurain, N. S., Stamminger, T., Caplan, O., Saleh, N., Efferth, T., Marschall, M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587106 · Cited by 157 · see citing works

NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy

Nakanishi, H., Kawashima, Y., Kurima, K., Chae, J. J., Ross, A. M., Pinto-Patarroyo, G. P., Patel, S. K., Muskett, J. A., Ratay, J. S., Chattaraj, P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702946114 · Cited by 154 · see citing works

Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection

Tseng, C.-T. K., Perrone, L. A., Zhu, H., Makino, S., & Peters, C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7977 · Cited by 152 · see citing works

Anti‐Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives

Shi, C., Li, H., Yang, Y., & Hou, L. (2015) · Mediators of Inflammation · doi:10.1155/2015/435713 · Cited by 151 · see citing works

Monocyte programmed death ligand-1 expression after 3–4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study

Shao, R., Fang, Y., Han, Y., Zhao, L., Jiang, Z., & Li, C. (2016) · Critical Care · doi:10.1186/s13054-016-1301-x · Cited by 148 · see citing works

Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro

Yen, Y., Liao, F., Hsiao, C.-H., Kao, C., Chen, Y., & Wu‐Hsieh, B. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2684-2693.2006 · Cited by 140 · see citing works

Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs

An, J., Minie, M., Sasaki, T., Woodward, J. J., & Elkon, K. B. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-043015-123453 · Cited by 140 · see citing works

“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”

Singh, A. K., Singh, R., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.017 · Cited by 130 · see citing works

A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease

Ferrey, A., Choi, G., Hanna, R. M., Chang, Y., Tantisattamo, E., Ivaturi, K., Park, E., Nguyen, L., Wang, B., Tonthat, S., et al. (2020) · American Journal of Nephrology · doi:10.1159/000507417 · Cited by 127 · see citing works

Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19

Ouyang, Y., Yin, J., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa462 · Cited by 127 · see citing works

Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses

Hou, L., He, S., Li, X., Yang, Y., He, P., Zhou, Y., Zhu, F., Yang, Y., Li, Y., Tang, W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30392 · Cited by 121 · see citing works

Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease

Wang, Z., Zhu, L., Nguyen, T. H. O., Wan, Y., Sant, S. A., Quiñones‐Parra, S. M., Crawford, J. C., Eltahla, A. A., Rizzetto, S., Bull, R. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03243-7 · Cited by 121 · see citing works

Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence

Lenzer, J. (2020) · BMJ · doi:10.1136/bmj.m1335 · Cited by 115 · see citing works

Immune suppressive properties of artemisinin family drugs

Hou, L., & Huang, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.002 · Cited by 97 · see citing works

Investigation of the immunosuppressive activity of artemether on T‐cell activation and proliferation

Wang, J., Tang, W., Shi, L., Wan, J., Zhou, R., Ni, J., Fu, Y., Yang, Y., Li, Y., & Zuo, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707137 · Cited by 94 · see citing works

Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells

Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P., & Julkunen, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000351 · Cited by 90 · see citing works

The Use of an Herbal Formula by Hospital Care Workers During the Severe Acute Respiratory Syndrome Epidemic in Hong Kong to Prevent Severe Acute Respiratory Syndrome Transmission, Relieve Influenza-Related Symptoms, and Improve Quality of Life: A Prospective Cohort Study

Lau, J. T. F., Leung, P., Wong, E. L., Fong, C., Cheng, K.-F., Zhang, S. C., Lam, C. W. K., Wong, V. C. W., Choy, K. M., & Ko, W. M. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.49 · Cited by 85 · see citing works

Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesisPreprint

Li, J., Guo, M., Tian, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.31.019216 · Cited by 83 · see citing works

Using Herbal Medicine as a Means of Prevention Experience During the SARS Crisis

Lau, T. F., Leung, P. C. K., Wong, E. L., et al. (2005) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x05002965 · Cited by 79 · see citing works

First Successful Combination of ECMO with Cytokine Removal Therapy in Cardiogenic Septic Shock: A Case Report

Bruenger, F., Kizner, L., Weile, J., et al. (2015) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000382 · Cited by 77 · see citing works

SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages

Wang, J., Hou, L., Yang, Y., et al. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.138 · Cited by 76 · see citing works

Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patientsPreprint

Chen, X., Ling, J., Mo, P., Zhang, Y., Jiang, Q., Ma, Z., Cao, Q., Hu, W., Zou, S., Chen, L., et al. (2020) · medRxiv · doi:10.1101/2020.03.03.20030437 · Cited by 75 · see citing works

Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus

Germi, R., Mariette, C., Alain, S., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.10.014 · Cited by 72 · see citing works

The new water‐soluble artemisinin derivative SM905 ameliorates collagen‐induced arthritis by suppression of inflammatory and Th17 responses

Wang, J., Tang, W., Zhou, R., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.11 · Cited by 72 · see citing works

Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-κB activation

Li, B., Li, J., Pan, X., Ding, G., Cao, H., Jiang, W., Zheng, J., & Zhou, H. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.006 · Cited by 70 · see citing works

Cytokine Storm Syndrome

(2019) · Springer eBooks · doi:10.1007/978-3-030-22094-5 · Cited by 70 · see citing works

Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation

Cao, T., Jin, S., Fei, D., Kang, K., Jiang, L., Lian, Z.-Y., Pan, S., Zhao, M., & Zhao, M. (2015) · Inflammation · doi:10.1007/s10753-015-0290-2 · Cited by 66 · see citing works

Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome

Odièvre, M., de Marcellus, C., Pointe, H. D. L., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25855 · Cited by 61 · see citing works

Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice

Huang, X., Xie, Z., Liu, F., et al. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.001 · Cited by 60 · see citing works

P2X7R: A potential key regulator of acute gouty arthritis

Tao, J., Zhang, Y., & Li, X.-P. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.007 · Cited by 55 · see citing works

FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS

Dougados, M., van der Heijde, D. M. F. M., Bingham, C. O., Taylor, P. C., Fallon, L., Woolcott, J. C., Brault, Y., Wang, L., & Kessouri, M. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-eular.949 · Cited by 52 · see citing works

Plasma Levels of the Interleukin‐6 Cytokine Family in Persons with SeverePlasmodium falciparumMalaria

Wenisch, C., Linnau, K. F., Looaresuwan, S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314630 · Cited by 51 · see citing works

Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6

Fan, M., Li, Y., Yao, C.-H., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.015 · Cited by 48 · see citing works

Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure

Träger, K., Schütz, C., Fischer, G., et al. (2016) · Case Reports in Critical Care · doi:10.1155/2016/9852073 · Cited by 47 · see citing works

Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner

Huang, X., Liu, W. Q., Zhou, Y., Hao, C., Zhou, Y., Zhang, C., Sun, C., Luo, Z., & Tang, S. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4387 · Cited by 44 · see citing works

Artesunate ameliorates severe acute pancreatitis (SAP) in rats by inhibiting expression of pro-inflammatory cytokines and Toll-like receptor 4

Cen, Y., Liu, C., Li, X., Yan, Z., Kuang, M., Su, Y., Pan, X., Qin, R., Liu, X., Zheng, J., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.007 · Cited by 41 · see citing works

SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-KB pathways in RAW 264.7 macrophages

Junxia, Wang, Li-Fei, et al. (2009) · 中国药理学报：英文版 · Cited by 41 · see citing works

Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway

Kuang, M., Cen, Y., Qin, R., Shang, S., Zhai, Z., Liu, C., Pan, X., & Zhou, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489982 · Cited by 40 · see citing works

Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis

Busch, L. M., Sun, J., Cui, X., Eichacker, P. Q., & Torabi‐Parizi, P. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-019-0290-x · Cited by 39 · see citing works

Artemisinin protects mice against burn sepsis through inhibiting NLRP3 inflammasome activation

Long, H., Xu, B., Luo, Y., & Luo, K. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.12.075 · Cited by 38 · see citing works

Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib

Jacobs, J. D., Clark‐Snustad, K., & Lee, S. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa093 · Cited by 36 · see citing works

Decoding the enigma of antiviral crisis: Does one target molecule regulate all?

Mahmud-Al-Rafat, A., Majumder, A., Rahman, K. M. T., Hasan, A. M. M., Islam, K. M. D., Taylor-Robinson, A. W., & Billah, M. M. (2019) · Cytokine · doi:10.1016/j.cyto.2018.12.008 · Cited by 34 · see citing works

Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression

Cheng, Z., Qi, R., Li, L., Liu, Q., Zhang, W., Zhou, X., Xu, D., Allen, T. D., Pan, S., & Liu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.078 · Cited by 28 · see citing works

The Lesson of Supplementary Treatment with Chinese Medicine on Severe Laboratory-Confirmed SARS Patients

Hsu, C.-H., Hwang, K., Chao, C.-L., et al. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06004405 · Cited by 25 · see citing works

Hemozoin‐induced activation of human monocytes toward M2‐like phenotype is partially reversed by antimalarial drugs—chloroquine and artemisinin

Bobade, D., Khandare, A. V., Deval, M., et al. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.651 · Cited by 23 · see citing works

Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria

Du, Y., Chen, G., Zhang, X., Yu, C., Cao, Y., & Cui, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.008 · Cited by 22 · see citing works

Artemisinin inhibits lipopolysaccharide-induced interferon-β production in RAW 264.7 cells: Implications on signal transducer and activator of transcription-1 signaling and nitric oxide production

Park, K. H., Yoon, Y. D., Han, S., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.09.012 · Cited by 21 · see citing works

Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin

Ma, C., Wong, C. K., Wong, B. C. K., et al. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21383 · Cited by 14 · see citing works

Hyperimmune IV Immunoglobulin Treatment of 2009 Influenza A(H1N1): Response

Hung, I. F., & Yuen, K. (2013) · CHEST Journal · doi:10.1378/chest.13-0571 · Cited by 9 · see citing works

[Preparation of liposomal artesunate dry powder inhalers and the effect on the acute lung injury of rats].

Hu, Y., Li, M., Zhang, T., et al. (2016) · PubMed · Cited by 8 · see citing works

Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction

Idowu, A. O., Bhattacharyya, S., Gradus, S. M., Oyibo, W. A., George, Z., Black, C. M., Igietseme, J. U., & Azenabor, A. A. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27350 · Cited by 5 · see citing works

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Woodruff, M. C., Ramonell, R. P., Nguyen, D. C., Cashman, K. S., Saini, A. S., Haddad, N. S., Ley, A. M., Kyu, S., Howell, J. C., Ozturk, T., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00814-z · Cited by 791 · see citing works

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works

Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis

Evangelou, K., Veroutis, D., Paschalaki, K., Foukas, P. G., Lagopati, N., Dimitriou, M., Papaspyropoulos, A., Konda, B., Hazapis, O., Polyzou, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02951-2021 · Cited by 98 · see citing works

Biomarkers of post-covid depression

Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works

Biologically informed deep learning to query gene programs in single-cell atlases

Lotfollahi, M., Rybakov, S., Hrovatin, K., Hediyeh-zadeh, S., Talavera-López, C., Misharin, A. V., & Theis, F. J. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01072-x · Cited by 100 · see citing works

Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation

Lu, R. X. Z., Lai, B. F. L., Rafatian, N., Gustafson, D., Campbell, S. B., Banerjee, A., Kozak, R., Mossman, K., Mubareka, S., Howe, K. L., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc00817j · Cited by 58 · see citing works

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series

Basnet, A., Shrestha, M. R., Thapa, R., et al. (2022) · Journal of Nepal Medical Association · doi:10.31729/jnma.7364 · Cited by 2 · see citing works

Modulation of Covid‐19 cytokine storm by tocilizumab

Boretti, A. A., & Banik, B. K. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27380 · Cited by 15 · see citing works

Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia

Wang, X., Zhang, B., Zhang, Q., et al. (2024) · Cancer · doi:10.1002/cncr.35316 · Cited by 18 · see citing works

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 876 · see citing works

Tocilizumab-Refractory Cytokine Release Syndrome (CRS) Triggered By Chimeric Antigen Receptor (CAR)-Transduced T Cells May Have Distinct Cytokine Profiles Compared to Typical CRS

Ishii, K., Shalabi, H., Yates, B., et al. (2016) · Blood · doi:10.1182/blood.v128.22.3358.3358 · Cited by 27 · see citing works